CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 70% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. Please refer to our Risk Disclosure Statement
Roche Holding (ROG) is a Swiss biotech company, established in 1896 and headquartered in Basel, Switzerland. The company provides innovative pharmaceuticals, solutions for diagnostics and products for researchers across the following disease areas: oncology, neuroscience, infectious diseases, immunology, cardiovascular and metabolism, ophthalmology, haematology, haemophilia, and respiratory diseases. Roche employs more than 90,000 staff members in over 100 countries globally. Roche is listed on the SIX Swiss Exchange. Explore the Roche Holding Par share price (ROG) at Capital.com.
The last of the Magnificent Seven have reported, delivering mixed results. Meanwhile, according to FactSet, the S&P 500 is set for negative earnings growth for Q4, with estimates for the next quarter also downgraded.
14:43, 2 February 2024
Read our reviews to find out more about us
Read the feedback from our clients, whatever their experience level.
Showing our 4 & 5 star reviews. The specific details of the user have been intentionally anonymised to safeguard their privacy pursuant to GDPR requirements.